<DOC>
	<DOCNO>NCT01675115</DOCNO>
	<brief_summary>The objective study investigate efficacy safety BNG-1 patient ischemic stroke . The efficacy assessment base functional outcome safety review adverse event laboratory examination .</brief_summary>
	<brief_title>Efficacy BNG-1 Treat Acute Ischemic Stroke</brief_title>
	<detailed_description>The primary endpoint perform 12 week study drug administer compare favorable rate treatment Aspirin alone combination treatment BNG-1 Aspirin patient ischemic stroke . The favorable therapy determine follow occurs : alive , Modified Rankin Scale ( MRS ) &lt; 3 , Barthel Index ( BI ) &gt; = 60 . Secondary objective compare follow : 1 . Compare favorable rate one week study drug administer end treatment ( Week 4 ) 4 week follow-up ( Week 8 ) either Aspirin alone combination treatment BNG-1 Aspirin . 2 . Compare mean change Barthel Index ( BI ) , evaluation time-point either Aspirin alone combination treatment BNG-1 Aspirin . 3 . Compare mean change National Institute Health Stroke Scale ( NIHSS ) evaluation time-point either Aspirin alone combination treatment BNG-1 Aspirin . 4 . Compare Modified Rankin Scale ( MRS ) evaluation time-point either Aspirin alone combination treatment BNG-1 Aspirin . 5 . Compare change Extended Glasgow Outcome Scale ( GOS-E ) evaluation time-point either Aspirin alone combination treatment BNG-1 Aspirin .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>1 . Both gender age 20 65 ( subject least 20 year old yet 66 ) . 2 . Clinical diagnosis ischemic stroke , cause measurable neurological deficit . 3 . Onset symptom ischemic stroke within 10 day initiation treatment study drug . 4 . Patients total National Institutes Health Stroke Scale ( NIHSS ) 8 22 inclusive time randomization . 5 . Patients total Barth Index ( BI ) less 60 Modified Rankin Scale ( MRS ) least 3 time randomization . 6 . No previous history stroke previous stroke Modified Rankin Scale &lt; 1 . 7 . Patient must CT MRI examination compatible clinical diagnosis acute ischemic stroke . 8 . Signed informed consent patient legally authorize representative . 1 . Patient major symptom rapidly improve time randomization . 2 . History stroke within previous 3 month , exclude TIA . 3 . Patient CT MRI scan evidence nonischemic mechanism , subarachnoid hemorrhage , primary intracerebral intraventricular hemorrhage . 4 . Patients know suspected prior intracranial haemorrhage history brain injury brain tumor . 5 . Patient document history atrial fibrillation occur 6 month randomization . 6 . Hypertension , define systolic blood pressure &gt; 185 mmHg diastolic blood pressure &gt; 110 mmHg require aggressive ( eg , intravenous antihypertensive ) treatment reduce blood pressure within limit . 7 . Recurrent peptic ulcer gastrointestinal bleeding document radiographic endoscopic mean within past 3 month . 8 . Pregnant lactate woman woman childbearing potential practicing reliable birth control . 9 . Platelet count le 100,000 cells/ml . 10 . Activated partial thromboplastin time ( aPTT ) prolongation great 2 second upper limit normal local laboratory . 11. International normalize ratio ( INR ) great equal 1.4 . 12 . Uncontrolled hyperglycemia ( Sugar AC &gt; 200 mg/dl ) . 13 . History alcohol drug abuse previous 3 month . 14 . History hypersensitivity intolerance study drug aspirin . 15 . Neurological ( present stroke ) psychiatric condition may affect patient 's functional status and/or may interfere patient 's assessment . 16 . Previously BRAINStudy participation research protocol investigation pharmaceutical agent innovative invasive procedure within past 30 day . 17 . Any know clinically significant medical disorder ( e.g. , severe comorbid disease dementia , transient cerebral ischemia , low gastrointestinal bleeding , bleed diathesis , hepatorenal disease , cancer , AIDS ) . 18 . Patients receive anticoagulant agent , antiplatelet agent ( except Aspirin ) , thrombolytic 48hour randomization .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Ischemic stroke</keyword>
	<keyword>Traditional Chinese Medication</keyword>
	<keyword>Aspirin</keyword>
</DOC>